65. 原発性免疫不全症候群 Primary immunodeficiency Clinical trials / Disease details

臨床試験数 : 500 / 薬物数 : 614 - (DrugBank : 119) / 標的遺伝子数 : 92 - 標的パスウェイ数 : 217

1 trial found

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05531890 (ClinicalTrials.gov)	September 13, 2022	31/8/2022	Comparative Bioavailability of BetamethasoneOral Solution Metered Spray (GTX-102) in Healthy Subject ...	Crossover Study to Evaluate the Comparative Bioavailability, Pharmacokinetics, and Safety of GTX-102 ...	Ataxia Telangiectasia	Drug: GTX-102 medium dose fast Period 1 and Period 2;Drug: GTX-102 medium dose slow Period 1 and Perio ...	Acasti Pharma Inc.	NULL	Active, not recruiting	18 Years	55 Years	All	48	Phase 1	Canada

First Previous1Next Last